About ss innovations international inc - SSII
SS Innovations International, Inc. is a medical robotics company, which develops a fully autonomous medical robotic system using proprietary software. Its proprietary software integrates Artificial Intelligence (AI) and Deep Learning, or machine learning (DL). It focuses on research and development to an AI-enhanced robotics platform system that can be combined with proven medical devices, end-effectors, and surgical instruments. The company was founded by Barry F. Cohen on February 4, 2015 and is headquartered in Fort Lauderdale, FL.
SSII At a Glance
SS Innovations International, Inc.
1600 SE 15th Street
Fort Lauderdale, Florida 33316
| Phone | 1-733-755-3469 | Revenue | 42.41M | |
| Industry | Medical Specialties | Net Income | -12,127,387.00 | |
| Sector | Health Technology | 2025 Sales Growth | 106.114% | |
| Fiscal Year-end | 12 / 2026 | Employees | 483 | |
| View SEC Filings |
SSII Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 25.446 |
| Price to Book Ratio | 28.857 |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | -153.278 |
| Enterprise Value to Sales | 25.569 |
| Total Debt to Enterprise Value | 0.013 |
SSII Efficiency
| Revenue/Employee | 87,813.329 |
| Income Per Employee | -25,108.462 |
| Receivables Turnover | 2.354 |
| Total Asset Turnover | 0.726 |
SSII Liquidity
| Current Ratio | 1.86 |
| Quick Ratio | 1.209 |
| Cash Ratio | 0.348 |
SSII Profitability
| Gross Margin | 43.376 |
| Operating Margin | -19.218 |
| Pretax Margin | -19.241 |
| Net Margin | -28.593 |
| Return on Assets | -20.766 |
| Return on Equity | -46.937 |
| Return on Total Capital | -23.065 |
| Return on Invested Capital | -43.034 |
SSII Capital Structure
| Total Debt to Total Equity | 37.573 |
| Total Debt to Total Capital | 27.311 |
| Total Debt to Total Assets | 19.297 |
| Long-Term Debt to Equity | 6.117 |
| Long-Term Debt to Total Capital | 4.446 |